Home/Pipeline/TAK-648

TAK-648

Diabetic Macular Edema

Phase 2Status Unknown

Key Facts

Indication
Diabetic Macular Edema
Phase
Phase 2
Status
Status Unknown
Company

About Thermo Fisher Scientific

Thermo Fisher Scientific's mission is to enable its customers to make the world healthier, cleaner, and safer by providing the scientific tools and services that accelerate innovation. The company has achieved a dominant market position through strategic acquisitions, organic innovation, and the creation of an unparalleled, integrated ecosystem for the scientific community. Its strategy revolves around leveraging its scale and breadth to drive operational excellence, investing in high-growth areas like bioproduction and precision medicine, and selectively advancing an internal pipeline of novel therapeutics. With a market capitalization exceeding $178 billion, Thermo Fisher is a foundational pillar of the global life sciences industry.

View full company profile

Other Diabetic Macular Edema Drugs

DrugCompanyPhase
Not Specified (Ophthalmology Program)Therini BioClinical-stage
OHB-401Oak Hill BioPre-clinical
AXPAXLI (OTX-TKI)Ocular TherapeutixPhase 3
BGE-102BioAge LabsPhase 1b/2a
4D-1504D Molecular TherapeuticsPhase 3